Clinical Trials Browser

Interventional × Small Cell Lung Carcinoma × etirinotecan pegol × Clear all

NCT05158491 2022-01-05

Safety, Tolerability and Preliminary Efficacy of JK1201I in Patients With SCLC

Phase 1/2 Unknown

Small Cell Lung Carcinoma

NCT01876446 2020-03-17

Pegylated Irinotecan NKTR 102 in Treating Patients With Relapsed Small Cell Lung Cancer

Phase 2 Completed

38 enrolled 16 charts

Small Cell Lung Carcinoma